Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Logothetis

Showing results (521-530 of 1,104) with videos related to

Pageof 111
Sort By:
Minerva Ginecologica|April 22, 2011
The presence of CD40, CD40L and ADAM8 among endometriotic patientsK Panoulis, E Nieri, G Kaparos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1995
A phase I trial of intermittent high-dose alpha-interferon and dexamethasone in metastatic renal cell carcinomaR Amato, C Meyers, J Ellerhorst, et al.
ACS Omega|June 30, 2020
Protein Binding Pocket Optimization for Virtual High-Throughput Screening (vHTS) Drug DiscoveryDimitris Gazgalis, Mehreen Zaka, Bilal Haider Abbasi, et al.
Internal and Emergency Medicine|January 15, 2025
The variable relationship between the National Early Warning Score on admission to hospital, the primary discharge diagnosis, and in-hospital mortalityMark Holland, John Kellett, Stelios Boulitsakis-Logothetis, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 26, 2007
The effect of labeling parameters on perfusion-based fMRI in nonhuman primatesAnne C Zappe, Josef Pfeuffer, Hellmut Merkle, et al.
The Journal of Biological Chemistry|July 18, 2002
Inhibition of prostate tumor angiogenesis by the tumor suppressor CEACAM1Olga Volpert, Weiping Luo, Ta-Jen Liu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2002
A 20% dose reduction of the original CISCA/VB regimen allows better tolerance and similar survival rate in disseminated testicular non-seminomatous germ-cell tumors: final results of a phase III randomized trialK Fizazi, K A Do, X Wang, et al.
The Journal of Urology|October 1, 1994
Neoadjuvant cisplatin and interferon-alpha 2B in the treatment and organ preservation of penile carcinomaD Mitropoulos, M A Dimopoulos, A Kiroudi-Voulgari, et al.
Neuroimage|November 21, 2007
fMRI of the temporal lobe of the awake monkey at 7 TJozien B M Goense, Shih-Pi Ku, Hellmut Merkle, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|May 28, 2013
Spatial representations of temporal and spectral sound cues in human auditory cortexMarcus Herdener, Fabrizio Esposito, Klaus Scheffler, et al.
Pageof 111

Showing results (521-530 of 1,104) with videos related to

Sort By:
Pageof 111
Minerva Ginecologica|April 22, 2011
The presence of CD40, CD40L and ADAM8 among endometriotic patientsK Panoulis, E Nieri, G Kaparos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1995
A phase I trial of intermittent high-dose alpha-interferon and dexamethasone in metastatic renal cell carcinomaR Amato, C Meyers, J Ellerhorst, et al.
ACS Omega|June 30, 2020
Protein Binding Pocket Optimization for Virtual High-Throughput Screening (vHTS) Drug DiscoveryDimitris Gazgalis, Mehreen Zaka, Bilal Haider Abbasi, et al.
Internal and Emergency Medicine|January 15, 2025
The variable relationship between the National Early Warning Score on admission to hospital, the primary discharge diagnosis, and in-hospital mortalityMark Holland, John Kellett, Stelios Boulitsakis-Logothetis, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 26, 2007
The effect of labeling parameters on perfusion-based fMRI in nonhuman primatesAnne C Zappe, Josef Pfeuffer, Hellmut Merkle, et al.
The Journal of Biological Chemistry|July 18, 2002
Inhibition of prostate tumor angiogenesis by the tumor suppressor CEACAM1Olga Volpert, Weiping Luo, Ta-Jen Liu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2002
A 20% dose reduction of the original CISCA/VB regimen allows better tolerance and similar survival rate in disseminated testicular non-seminomatous germ-cell tumors: final results of a phase III randomized trialK Fizazi, K A Do, X Wang, et al.
The Journal of Urology|October 1, 1994
Neoadjuvant cisplatin and interferon-alpha 2B in the treatment and organ preservation of penile carcinomaD Mitropoulos, M A Dimopoulos, A Kiroudi-Voulgari, et al.
Neuroimage|November 21, 2007
fMRI of the temporal lobe of the awake monkey at 7 TJozien B M Goense, Shih-Pi Ku, Hellmut Merkle, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|May 28, 2013
Spatial representations of temporal and spectral sound cues in human auditory cortexMarcus Herdener, Fabrizio Esposito, Klaus Scheffler, et al.
Pageof 111